These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20192584)

  • 21. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
    Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M
    Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of fibroblast growth factor receptor 3 gene (FGFR3) A248C, S249C, G372C, and T375C mutations in bladder cancer.
    Dodurga Y; Tataroglu C; Kesen Z; Satiroglu-Tufan NL
    Genet Mol Res; 2011 Jan; 10(1):86-95. PubMed ID: 21264819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
    Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
    Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
    Demunter A; Ahmadian MR; Libbrecht L; Stas M; Baens M; Scheffzek K; Degreef H; De Wolf-Peeters C; van Den Oord JJ
    Cancer Res; 2001 Jun; 61(12):4916-22. PubMed ID: 11406571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
    Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
    Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H-ras-1 point mutations in soft tissue sarcomas.
    Wilke W; Maillet M; Robinson R
    Mod Pathol; 1993 Mar; 6(2):129-32. PubMed ID: 8483882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
    Nollau P; Moser C; Weinland G; Wagener C
    Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder].
    Yu D; Liu F; Liang Z
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):202-5. PubMed ID: 9275651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.
    Stoehr R; Brinkmann A; Filbeck T; Gamper C; Wild P; Blaszyk H; Hofstaedter F; Knuechel R; Hartmann A
    Oncol Rep; 2004 Jan; 11(1):137-41. PubMed ID: 14654916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
    Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
    Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 - molecular soldier's mutations in bladder cancer in the Kashmiri population.
    Nanda MS; Shah ZA; Sameer AS; Syeed N; Murtaza I; Siddiqi MA; Ali A
    Asian Pac J Cancer Prev; 2011; 12(1):67-72. PubMed ID: 21517233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of ras gene mutations in gastrointestinal cancers.
    Shen C; Chang JG; Lee LS; Yang MJ; Chen TC; Lin KY; Lee MD; Chen PH
    J Formos Med Assoc; 1991 Dec; 90(12):1149-54. PubMed ID: 1686883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area.
    Sameer AS; ul Rehman S; Pandith AA; Syeed N; Shah ZA; Chowdhri NA; Wani KA; Siddiqi MA
    Saudi J Gastroenterol; 2009; 15(4):244-52. PubMed ID: 19794270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infrequent involvement of mutations on neurofibromatosis type 1, H-ras, K-ras and N-ras in urothelial tumors.
    Uchida T; Wada C; Ishida H; Egawa S; Ao T; Yokoyama E; Koshiba K
    Urol Int; 1995; 55(2):63-7. PubMed ID: 8533197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Low incidence of mutations in codon 12 of the c-K-ras gene in bladder cancer].
    Ejarque MJ; Villanueva A; Chechile G; Regalado R; Errando C; Algaba F; Capella G; Lluis F; Villavicencio H; Vicente J
    Actas Urol Esp; 1995 Sep; 19(8):599-603. PubMed ID: 8669326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations.
    Hollstein MC; Peri L; Mandard AM; Welsh JA; Montesano R; Metcalf RA; Bak M; Harris CC
    Cancer Res; 1991 Aug; 51(15):4102-6. PubMed ID: 1855226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of human bladder carcinomas for the presence of Ha-ras codon 12 mutation.
    Cattan N; Saison-Behmoaras T; Mari B; Mazeau C; Amiel JL; Rossi B; Gioanni J
    Oncol Rep; 2000; 7(3):497-500. PubMed ID: 10767358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of activating ras mutations in morphologically characterized thyroid nodules.
    Ezzat S; Zheng L; Kolenda J; Safarian A; Freeman JL; Asa SL
    Thyroid; 1996 Oct; 6(5):409-16. PubMed ID: 8936664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.